IMDA Quarterly Education Session

  • Thu, February 04, 2021
  • 6:30 PM - 7:30 PM
  • via Zoom


Registration is closed

IMDA Quarterly Education Session

Thursday, February 4, 2021, 6:30-7:30 PM

FREE Virtual Session

COVID-19 Update:

Vaccine and Treatment Options


 Samuel Gurevitz PharmD

Assistant Professor, Butler University

College of Pharmacy & Health Sciences

      Monica Ott MD, CMD    

CCM Market Medical Director


Zoom Meeting ID: 846 3884 5696, Password: IMDA

Meeting Link

Learning Objectives: At the end of the session, the participants will be able to discuss the indications for dexamethasone and monoclonal antibodies in patients with COVID, describe the mechanism of action and efficacy of the mRNA COVID vaccines, and describe ways to overcome Covid-19 vaccine hesitancy, particularly regarding safety and emergency use authorization.

Accreditation StatementIn support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and IMDA- The Indiana Society for Post-Acute and Long-Term Care Medicine. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Indiana University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure SummaryIndiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that IUSM may identify and resolve any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor. There are no relevant financial relationships with a commercial interest for anyone who was in control of the content of this activity. Indiana University School of Medicine (IUSM) defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

IMDA is a 501(c)6 non-profit organization. PO Box 34067, Indianapolis, IN 46234

Powered by Wild Apricot Membership Software